Kolltan Pharmaceuticals, Inc.
Records under this name other than the patents Kolltan Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Kolltan Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,189,907 | Polynucleotides encoding anti-KIT antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,793,639 | Methods of treating by administering anti-kit antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,884,699 | Anti-KIT antibodies and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,605,081 | Polynucleotides encoding anti-kit antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,184,007 | Methods of treating a kit-associated cancer by administering anti-kit antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,781,267 | Methods of treating by administering anti-kit antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,334,332 | Anti-kit antibodies Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,891,452 | Anti-kit antibodies and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,239,943 | Treatment of Eosinophil or Mast Cell Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,774,146 | Treatment of Eosinophil or Mast Cell Related Disorders Formerly held In force · High confidence | In force | High confidence |